Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,575 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion.
Asaoka Y, Tada M, Ikenoue T, Seto M, Imai M, Miyabayashi K, Yamamoto K, Yamamoto S, Kudo Y, Mohri D, Isomura Y, Ijichi H, Tateishi K, Kanai F, Ogawa S, Omata M, Koike K. Asaoka Y, et al. Among authors: yamamoto k, yamamoto s. Biochem Biophys Res Commun. 2010 Apr 16;394(4):1042-6. doi: 10.1016/j.bbrc.2010.03.120. Epub 2010 Mar 21. Biochem Biophys Res Commun. 2010. PMID: 20331976
NOTES and endoscopic pancreatic necrosectomy for the GI endoscopist.
Isayama H, Yamamoto K, Mizuno S, Yashima Y, Togawa O, Kogure H, Sasaki T, Sasahira N, Nakai Y, Hirano K, Tsujino T, Tada M, Kawabe T, Omata M. Isayama H, et al. Among authors: yamamoto k. J Hepatobiliary Pancreat Surg. 2009;16(3):270-3. doi: 10.1007/s00534-009-0083-9. Epub 2009 Apr 7. J Hepatobiliary Pancreat Surg. 2009. PMID: 19347662 Review.
Diagnostic utility of biopsy specimens for autoimmune pancreatitis.
Hirano K, Fukushima N, Tada M, Isayama H, Mizuno S, Yamamoto K, Yashima Y, Yagioka H, Sasaki T, Kogure H, Nakai Y, Sasahira N, Tsujino T, Kawabe T, Fukayama M, Omata M. Hirano K, et al. Among authors: yamamoto k. J Gastroenterol. 2009;44(7):765-73. doi: 10.1007/s00535-009-0052-8. Epub 2009 May 9. J Gastroenterol. 2009. PMID: 19430718 Clinical Trial.
A pilot study for combination chemotherapy using gemcitabine and S-1 for advanced pancreatic cancer.
Nakai Y, Isayama H, Sasaki T, Sasahira N, Ito Y, Kogure H, Togawa O, Matsubara S, Arizumi T, Yagioka H, Yashima Y, Kawakubo K, Mizuno S, Yamamoto K, Hirano K, Tsujino T, Ijichi H, Toda N, Tada M, Kawabe T, Omata M. Nakai Y, et al. Among authors: yamamoto k. Oncology. 2009;77(5):300-3. doi: 10.1159/000259616. Epub 2009 Nov 17. Oncology. 2009. PMID: 19923869
Bezafibrate for the treatment of primary sclerosing cholangitis.
Mizuno S, Hirano K, Tada M, Yamamoto K, Yashima Y, Yagioka H, Kawakubo K, Ito Y, Kogure H, Sasaki T, Arizumi T, Togawa O, Matsubara S, Nakai Y, Sasahira N, Tsujino T, Isayama H, Kawabe T, Omata M, Koike K. Mizuno S, et al. Among authors: yamamoto k. J Gastroenterol. 2010 Jul;45(7):758-62. doi: 10.1007/s00535-010-0204-x. Epub 2010 Feb 3. J Gastroenterol. 2010. PMID: 20127368
Impact of S-1 on the survival of patients with advanced pancreatic cancer.
Nakai Y, Isayama H, Sasaki T, Sasahira N, Ito Y, Kogure H, Togawa O, Matsubara S, Arizumi T, Yagioka H, Yashima Y, Kawakubo K, Mizuno S, Yamamoto K, Hirano K, Tsujino T, Ijichi H, Tateishi K, Toda N, Tada M, Omata M, Koike K. Nakai Y, et al. Among authors: yamamoto k. Pancreas. 2010 Oct;39(7):989-93. doi: 10.1097/MPA.0b013e3181d91936. Pancreas. 2010. PMID: 20467352
Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
Sasaki T, Isayama H, Nakai Y, Togawa O, Kogure H, Ito Y, Yamamoto K, Mizuno S, Yagioka H, Yashima Y, Kawakubo K, Arizumi T, Matsubara S, Sasahira N, Hirano K, Tsujino T, Toda N, Tada M, Omata M, Koike K. Sasaki T, et al. Among authors: yamamoto k. Cancer Chemother Pharmacol. 2011 Apr;67(4):847-53. doi: 10.1007/s00280-010-1360-7. Epub 2010 Jun 20. Cancer Chemother Pharmacol. 2011. PMID: 20563811
Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer.
Sasaki T, Isayama H, Nakai Y, Mizuno S, Yamamoto K, Yagioka H, Yashima Y, Kawakubo K, Kogure H, Togawa O, Matsubara S, Sasahira N, Hirano K, Tsujino T, Tada M, Omata M, Koike K. Sasaki T, et al. Among authors: yamamoto k. Invest New Drugs. 2011 Dec;29(6):1488-93. doi: 10.1007/s10637-010-9485-4. Epub 2010 Jul 6. Invest New Drugs. 2011. PMID: 20607585 Clinical Trial.
15,575 results
You have reached the last available page of results. Please see the User Guide for more information.